US 8921354
Heterocyclic compound
granted A61KA61K31/519A61K31/5377
Quick answer
US patent 8921354 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/519, A61K31/5377, A61K31/541, A61K31/55